PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Fresenius Medical Care AG

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Fresenius Medical Care AG's yearly results (2022–2025), compared with companies in Germany. Tap ? on any ratio for what it means.

What stands out

  • Profit Cash Ratio: Over the last 3 years, every €100 of reported profit came with €382 of operating cash. Higher than 94% of companies in Germany.
  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 86% of companies in Germany.
  • Tangible Assets Ratio: Of every €100 the company owns, €52 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 86% of companies in Germany.

Where €100 of sales goes

€91Operating costs€2.0Interest€5.0Net profit€2.2Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

€382

Over the last 3 years, every €100 of reported profit came with €382 of operating cash.

Higher than 94% of companies in Germany.

Self-Funding Ratio

3.3×

Over the last 3 years its own operating cash covered its investment spending (capex) 3.3 times.

Higher than 74% of companies in Germany.

Cash Locked Ratio

€24

For every €100 of sales, €24 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against €26 tied up three years earlier.

More money tied up than 62% of companies in Germany.

Growth quality

Steadiness Ratio

2/3 · 2/3

Sales grew in 2 of the last 3 years; profit grew in 2 of 3.

Steadier than 57% of companies in Germany.

Growth Efficiency Ratio

—

Sales barely changed

Sales changed by +1% in 3 years, too little to measure extra profit per extra sales.

Asset Productivity Ratio

+1% / -13%

In 3 years sales changed by +1% while total assets changed by -13%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

1.7×

Debt due within a year is covered 1.7 times by its yearly operating cash.

Lower than 65% of companies in Germany.

Cash Cushion Ratio

−86%

Debt, after subtracting cash, equals 86% of its market value (net debt).

Lower than 82% of companies in Germany.

Tangible Assets Ratio

52%

Of every €100 the company owns, €52 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 86% of companies in Germany.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 86% of companies in Germany.

Shareholders

Shareholder Slice Ratio

−5%

Share count fell 5% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 55% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Fresenius Medical Care AG owes €0.57 for every €1 it owns. Net profit rose 82% in the year to Dec 2025, and grew 13% a year on average over 3 years.

Compared with companies in Germany · latest annual results Dec 2025.

P/E ratio

11.8

Investors pay €11.8 for every €1 of Fresenius Medical Care AG's yearly profit, lower than 82% of companies in Germany.

P/B ratio

0.83

The share price is 0.83 times Fresenius Medical Care AG's book value per share, lower than 83% of companies in Germany.

Market cap

€10.4 B

The total market value of all of Fresenius Medical Care AG's shares at today's price (share price × number of shares), smaller than 88% of companies in Germany. PosiCap size class: Tito Cap.

Net worth (book value)

€12.6 B

What Fresenius Medical Care AG would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

€47.19

Net worth divided by the number of shares. The share price of €39.18 is 0.8 times this, which is the P/B above.

Return on equity (ROE)

8.5%

Fresenius Medical Care AG earned 8.5% on its shareholders' money over the last year, lower than 64% of companies in Germany.

Owes vs Owns

0.57×

Fresenius Medical Care AG owes €0.57 for every €1 it owns (moderate), lower than 67% of companies in Germany.

Dividend yield

3.78%

Fresenius Medical Care AG pays 3.78% of its share price as dividends a year, higher than 66% of dividend-paying companies in Germany.

Revenue growth

+2%

Revenue rose 2% in the year to Dec 2025, and grew 0% a year on average over 3 years.

Profit growth

+82%

Net profit rose 82% in the year to Dec 2025, and grew 13% a year on average over 3 years.

Profit margin

5.0%

Fresenius Medical Care AG keeps €5 of every €100 of revenue as net profit.

Cash quality

2.7×

Cash from Fresenius Medical Care AG's business was 2.7× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

4.8×

Fresenius Medical Care AG's operating profit covered its interest costs 4.8 times in the year to Dec 2025.

Cash vs debt

Net debt

Fresenius Medical Care AG had €9.0 B more debt than cash (net debt) at Dec 2025.

Questions

What is Fresenius Medical Care AG's P/E ratio?

Investors pay €11.8 for every €1 of Fresenius Medical Care AG's yearly profit, lower than 82% of companies in Germany.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Fresenius Medical Care AG: €10.4 B ÷ €12.6 B (30 Jun 2026) = 0.8.

What is Fresenius Medical Care AG's return on equity?

Fresenius Medical Care AG earned 8.5% on its shareholders' money over the last year, lower than 64% of companies in Germany.

How much does Fresenius Medical Care AG owe compared with what it owns?

Fresenius Medical Care AG owes €0.57 for every €1 it owns (moderate), lower than 67% of companies in Germany.

Does Fresenius Medical Care AG pay a dividend?

Yes. Fresenius Medical Care AG pays 3.78% of its share price as dividends a year, higher than 66% of dividend-paying companies in Germany.

Is Fresenius Medical Care AG's revenue growing?

Revenue rose 2% in the year to Dec 2025, and grew 0% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.